Sugi Predict

Sugi Predict / Compounds / SCHEMBL20399181

SCHEMBL20399181

SCHEMBL20399181

CCS(=O)(=O)c1cccc(NC(=O)O)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ TSHR P16473 1/20 0.39
▸ CA1 P00915 4/20 0.39
▸ CA2 P00918 4/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ APEX1 P27695 1/20 0.38
▸ GPR35 Q9HC97 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ KAT6A Q92794 1/20 0.37
▸ DDR1 Q08345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28340525 0.82 CA1 (0.39) MEN1KMT2ATSHRCA1CA2
SCHEMBL20399490 0.81 RXFP1 (0.43) CA1CA2HPGDDDR1
Carbamic Acid SCHEMBL28340527 0.73 KYNU (0.42) CA1CA2MAPTCYP1A2CYP3A4
SCHEMBL776476 0.72 PTGES2 (0.44) KMT2AAPEX1KAT6A
SCHEMBL2089517 0.72 KMT2A (0.52) MEN1KMT2ASMN1; SMN2HTTTP53
SCHEMBL20399208 0.72 MEN1 (0.41) MEN1KMT2ASMN1; SMN2MAPTHPGD
SCHEMBL16759143 0.71 PARP1 (0.42) MEN1KMT2ATSHRCA1CA2
SCHEMBL28247231 0.70 MAPK1 (0.53) TSHRCA1CA2SMN1; SMN2CYP1A2
SCHEMBL15163036 0.70 ALDH1A1 (0.46) MEN1KMT2ASMN1; SMN2MAPTHPGD
SCHEMBL10575731 0.70 CA12 (0.48) CA1CA2EPHX2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208947-A1 JAK1 SELECTIVE INHIBITORS ASTRAZENECA AB (SE) 2024-06-27 — — US disclosed
US-11897869-B2 JAK1 selective inhibitors ASTAZENECA AB (SE) 2024-02-13 — — US disclosed
EP-4219470-A1 JAK1 SELECTIVE INHIBITORS Astrazeneca AB (SE) 2023-08-02 — — EP disclosed
US-20210188821-A1 JAK1 SELECTIVE INHIBITORS ASTRAZENECA PHARMACEUTICALS LP 2021-06-24 — — US disclosed
US-10961228-B2 JAK1 selective inhibitors ASTRAZENECA AB (SE) 2021-03-30 — — US disclosed
WO-2018134213-A1 JAK1 SELECTIVE INHIBITORS ASTRAZENECA AB (SE) 2018-07-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11897869-B2 JAK1 selective inhibitors JAK1, JAK2, JAK3 MEN1 2067/4885KMT2A 982/4885TSHR 422/4885
US-20240208947-A1 JAK1 SELECTIVE INHIBITORS JAK1, JAK2, JAK3 MEN1 2067/4885KMT2A 982/4885TSHR 422/4885
US-20210188821-A1 JAK1 SELECTIVE INHIBITORS JAK1, JAK2, JAK3 MEN1 2067/4885KMT2A 982/4885TSHR 422/4885
US-10961228-B2 JAK1 selective inhibitors JAK1, JAK2, JAK3 MEN1 2067/4885KMT2A 982/4885TSHR 422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.